Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade
Beautiful Future and Blooming Future combine cutting‑edge efficiency and emissions‑reduction technologies to support more responsible global trade. ROTTERDAM,... Read more.
Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade
Beautiful Future and Blooming Future combine cutting‑edge efficiency and emissions‑reduction technologies to support more responsible global trade. ROTTERDAM,... Read more.
Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade
Beautiful Future and Blooming Future combine cutting‑edge efficiency and emissions‑reduction technologies to support more responsible global trade. ROTTERDAM,... Read more.
Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade
Beautiful Future and Blooming Future combine cutting‑edge efficiency and emissions‑reduction technologies to support more responsible global trade. ROTTERDAM,... Read more.
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay
GHENT, Belgium & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio... Read more.
Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland
Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network LONDON–(BUSINESS... Read more.
Kiabi Selects Navan to Centralise Global Travel Program
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform PALO ALTO, Calif.–(BUSINESS WIRE)–Navan (NASDAQ: NAVN),... Read more.
Kiabi Selects Navan to Centralise Global Travel Program
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform PALO ALTO, Calif.–(BUSINESS WIRE)–Navan (NASDAQ: NAVN),... Read more.
Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation
2.3 trillion yen in oncology revenue to be delivered by 2030 through the launch of 20 new indications across five medicines Identifying breakthrough generating technologies... Read more.
Almirall Continues Its Positive Trajectory in Q1 2026 in Line With Expectations – Led by 19.3% YoY Growth of Its European Dermatology Business
Almirall’s European Dermatology business delivered solid growth of 19.3% YoY, reaching €166.3 MM in Q1 2026, driven by strong momentum across key growth... Read more.